Desjardins Capital is the development capital fund management arm of Desjardins Group. It fuels the expansion of SMEs and cooperatives alike by providing them with strategic and financial support. Desjardins invests in Quebec-based companies.
Desjardins Capital Inc. issues securities on capital markets. It invests the proceeds in subordinated notes issued by Desjardins caisses of Quebec. The company was founded in 1987 and is headquartered in Lévis, Canada. Desjardins Capital Inc. is a subsidiary of Fédération des caisses Desjardins du Québec.It manages the assets of Desjardins Venture Capital, a limited partnership, six Desjardins investment regional funds, as well as Capital régional et coopératif Desjardins, a public fund whose assets under management are projected to reach $1.425-billion over the next 10 years. Desjardins Venture Capital makes its network and expertise available to businesses.
The Desjardins Group (French: Mouvement des caisses Desjardins) is a Canadian cooperative that is the largest federation of credit unions in North America and is counted among the World's Strongest Banks according to the Banker magazine. It was founded in 1900 in Levis, Quebec by Alphonse Desjardins. Its legal headquarters remains in Lévis but most of the executive management, including the CEO, is based in Montréal. As of 2017, there are 293 local credit unions (French: caisses populaires) operating 1,032 points of service and serving more than 7 million members and clients, mostly in Quebec and Ontario. In addition to retail banking, the Group has over 20 subsidiaries offering products and services related to insurance (Desjardins Financial Security, Desjardins General Insurance), real estate (Complexe Desjardins), venture capital funds (Desjardins Venture Capital) and brokerage (Desjardins Securities). The Desjardins Group, through subsidiary Développement international Desjardins, is also active in over 50 developing countries through technical assistance programs and various investments.
Desjardins Venture Capital has made 47 investments. One of their investments was on Mar 4, 2019, when they invested CA$15M in Emovi.Desjardins Venture Capital has raised a total of $120M in a single venture fund, Transatlantic Fund. This fund was announced on Jun 7, 2018, and raised a total of $120M.Desjardins Venture Capital has $17.1B in estimated revenue annually and competes with RBC Venture Partners, Toronto Dominion Bank Group, and Scotiabank.
Mylo is a Montreal-based company.
A company developing therapies for the treatment of genetic bone disorders.
A company developing protein therapeutics to treat inflammatory and immune diseases